top of page
News and events banner new.png
Small-orange-line

News and Events

ISSCR post.jpg

8-11 July 2026

Cytora presents at International Society for Stem Cell Research (ISSCR) conference in Montreal …

Read More
JP morgan_edited.jpg

12-15 January 2026

CYTORA Advances
Global Partnerships at
Bio Partnering
J.P. Morgan Week...

Read More
Partnership News&Events 1.jpg

January 2026

CYTORA,
Made Scientific, and
Zeo ScientifiX
Announce Partnership...

Read More
Bio Inter.jpg

22-25 June 2026

Cytora participates in
the BIO International Convention in
San Diego…

Read More
NIF banner.png

11 January 2026

CYTORA Showcases Neurodegenerative Pipeline at SACHS NIF in San Francisco...

Read More
Post header.jpg

6 May 2026

CYTORA appoints
Dr. Thomas E. Serena MD FACS FACHM MAPWCA to its Scientific Advisory Board...

Read More
Mini MIXiii Miami news and events.png

8 January 2026

CYTORA Strengthens U.S. Presence Following Strategic Florida Health-Tech Engagements...

Read More
Circle-bg
Cytora bottom logo

MENU

Cytora’s patented platform technology is based on the discovery of a novel and unique stem cell population in the human oral mucosa (hOMSC), the origin of which is the embryonic nervous system. hOMSC are endowed with properties of neural crest, neural and mesenchymal stem cells. Cytora’s products are allogeneic, off-the-shelf, easily scalable, with a very competitive cost of goods (COG). The products were found to be safe and effective in early phase clinical trials in two indications: Diabetic Foot Ulcers (DFU) and Multiple System Atrophy (MSA).

Our products have high potential for treating complicated multifactorial diseases such as chronic and neurodegenerative diseases, incurable wounds and autoimmune diseases.

ABOUT US

TECHNOLOGY

PIPELINE

TEAM

PUBLICATIONS

NEWS AND EVENTS

CONTACT US

CONTACT US

info@cytorastem.com

© 2022 Cytora. All rights reserved.

bottom of page